Dual GLP-1 / GIP agonist for powerful appetite suppression, blood-sugar control, and fat loss.
Tirzepatide is a once-weekly peptide that activates two incretin receptors — GLP-1 and GIP. Together they reduce appetite, slow stomach emptying so you feel full longer, and improve the body's insulin response, producing strong and consistent fat loss.
In the head-to-head SURMOUNT and SURPASS trial programs, tirzepatide produced mean weight reductions of roughly 15–21% over 72 weeks and outperformed semaglutide on both weight and blood-sugar endpoints. It is approved for both type 2 diabetes and chronic weight management.
Because it is a dual agonist, the appetite suppression is powerful — which is a benefit for adherence but means GI side effects (nausea, constipation, reflux) are common early on and are managed with a slow, stepwise dose increase every four weeks.
Powerful, well-documented fat loss through combined appetite suppression and improved satiety.
SURMOUNT-1: ~15–21% mean weight loss at 72 weeks
Superior glycemic control; frequently brings HbA1c into target ranges.
SURPASS program: outperformed semaglutide on HbA1c
Improvements in blood pressure, lipids, and markers tied to cardiovascular risk follow the weight loss.
Consistent secondary-endpoint improvements across trials
We rate every peptide honestly across four dimensions — and tell you what it's not.
Evidence Profile
Approved and backed by large phase 3 trials showing strong weight loss and superior glycemic control versus semaglutide.
Backed by human clinical data — one or more controlled human trials show a consistent effect.
Controlled trials & clinical data in people
Large SURMOUNT/SURPASS phase 3 program; FDA-approved for diabetes and weight management.
Preclinical results in animal models
Extensive preclinical incretin data supporting the dual-agonist mechanism.
How plausibly it works at a biological level
Dual GLP-1 / GIP agonism is well characterized.
Depth of documented safety in humans
Well-documented safety from large trials; GI effects are the main issue and are manageable.
Men focused on substantial weight loss or blood-sugar control who want the strongest approved incretin option
Titrate from 2.5 mg every 4 weeks. Keep protein high and train to preserve muscle. Stay hydrated and eat slowly to limit reflux and nausea.
Women seeking strong, sustained appetite control and fat loss
Can temporarily reduce oral contraceptive effectiveness during dose escalation — use a backup method for 4 weeks after each increase. Avoid in pregnancy. Often helpful for PCOS-related insulin resistance, but discuss with a clinician.
Widely used by women for weight management. May transiently reduce the effectiveness of oral contraceptives around dose escalation — use a backup method. Avoid in pregnancy.
This section is always free and never locked.
Contraindicated with personal or family history of medullary thyroid carcinoma or MEN 2.
Discontinue for suspected pancreatitis or gallbladder disease.
Start low (2.5 mg) and escalate every 4 weeks to manage GI side effects.
Prioritize protein intake and resistance training to preserve lean mass.
Slows gastric emptying — space apart from time-sensitive oral medications.
The effects most commonly reported with Tirzepatide, when they tend to show up, and how to manage them.
Eat smaller, lower-fat meals; titrate slowly; it usually fades within 1–2 weeks at a stable dose.
Hydrate well, add fiber, stay active. Tell your clinician if severe or persistent.
Prioritize protein and don't under-eat — rapid loss can cost muscle. Lift weights.
Rotate sites; let alcohol dry fully before injecting.
Stop immediately and seek medical care — this is a red-flag symptom.
Individual responses vary. Stop and consult a clinician for severe, persistent, or unexpected reactions.
14 steps with photos, pro tips, and a dosing calculator.
Unlock Full Guide7 days free. Then $24/month.
████████ ████
████████ ████
████████ ████
Dosing info requires Core or Pro
Unlock DosingAlways free. Never locked.
A preview of the member outcomes dashboard. Real, anonymized Tirzepatide results populate here as the community logs data.
See aggregated results from real users — benefit ratings, common goals, side effect frequency, and more.
Unlock with Core or ProGet the complete step-by-step guide, personalized dosing, and daily tracking.
View Full GuidePepCompass provides educational information only. Nothing on this platform constitutes medical advice, diagnosis, or treatment. All content is for informational and research purposes only. Always consult a licensed healthcare provider before starting any peptide protocol. Individual results vary.